hATTR Polyneuropathy in Russia

Clinical trial NCT06365593 · COMPLETED

Trial details

NCT number: NCT06365593
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Transthyretin Amyloidosis

Start date: 2023-12-29
Primary completion: 2024-05-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.